anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

129,421-129,480 of 319,975

filter-aware
286
The slide highlights a potential safety concern and a perceived lack of transparency or concern from the manufacturer's sales representative.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
287
The slide uses a Q&A format to provide evidence for the summary points listed in the title.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
288
Harmony Biosciences (HRMY)Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
289
The slide uses a Wikipedia table to explain DEA drug schedules to frame the competitive landscape.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
290
The slide uses direct quotes from KOLs and specialists to undermine a specific company value proposition.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
291
The slide uses a Q&A format to provide expert validation that scheduling is not a significant barrier to prescription.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
292
The slide uses direct quotes to expose a contradiction between the company's marketing (non-controlled status) and the actual physician experience (high administrative burden).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
293
The slide uses highlighted text to emphasize key negative sentiments from expert interviews.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
294
The slide uses a '>' symbol as a bullet point, suggesting a direct critique or callout.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
295
The slide uses a screenshot of the Wakix website to highlight the specific claim being challenged.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
296
The slide uses screenshots of two different websites to demonstrate consistent messaging across patient and HCP channels.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
297
The slide uses a 'preempt_rebuttal' or 'expose_contradiction' style to challenge the scientific validity of a drug's mechanism of action claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
298
The slide uses a 'fraud-exposure' approach by highlighting circular citations and methodological weaknesses in the foundational research.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
299
The slide uses scientific data to challenge the validity of the drug's efficacy claims by highlighting the high dosage required in animal models.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
300
Harmony Biosciences (HRMY)Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
301
The slide uses a specific academic paper to undermine the scientific premise of a drug's mechanism of action.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
302
The slide uses box-whisker plots to demonstrate a lack of correlation between histamine/metabolite levels and various sleep disorder etiologies.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
303
The slide uses a direct excerpt from a scientific paper to undermine a previous scientific claim.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
304
The slide uses a direct quote from a scientific editorial to discredit a previously held hypothesis regarding pitolisant's mechanism of action.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
305
The slide uses underlined text to emphasize key findings that contradict the company's narrative.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
306
Harmony Biosciences (HRMY)Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
307
The slide uses a combination of narrative argument and direct excerpts from regulatory documents to highlight a discrepancy in drug efficacy claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
308
The slide uses a strong accusatory tone, alleging fraudulent claims and intent to mislead the FDA.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
309
The slide uses a combination of summary points and direct excerpts from a pharmacology consultant's review to build a case of scientific negligence or misrepresentation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
310
The slide uses a specific scientific paper (Lin et al., 2007) to argue that the drug's mechanism is scientifically implausible based on the provided data.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
311
The slide uses expert testimony and raw data tables to challenge the validity of the reported pharmacokinetics.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
312
The slide uses a combination of summary text, a screenshot of the original study abstract, and a pull-quote from an expert review to discredit the study's findings.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
313
Includes a quote from a pharmacology consultant comparing pitolisant to antihistamines.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
314
The slide uses red boxes and text annotations to highlight specific data points in the charts that contradict expected clinical outcomes.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
315
The slide uses a blockquote style to present a critical allegation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
316
The slide uses a 'villain' narrative by comparing Harmony's practices to the Insys case and official government fraud alerts.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
317
The slide uses highlighted text to emphasize key admissions of quid pro quo arrangements.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
318
The slide uses direct quotes to expose potential unethical sales practices and reliance on key opinion leaders (KOLs) in the pharmaceutical industry.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
319
The slide uses a Q&A format to validate the thesis of extreme concentration in prescribing behavior.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
320
The slide uses highlighted text to emphasize key admissions regarding prescription volume and the criminal nature of the speaker program.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
321
The slide uses a Q&A format to highlight the 'quid pro quo' nature of the speaker programs.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
322
The slide presents a Q&A transcript excerpt highlighting a potential compliance issue regarding speaker programs and prescription volume.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
323
The slide uses highlighted text to emphasize key admissions of fraud/inducement.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
324
The slide uses a '>' character as a bullet point/indicator for the thesis statement.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
325
The slide uses a 'fraud-exposure' narrative by contrasting the official label with market reality.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
326
The slide uses direct quotes from former territory managers to substantiate allegations of fraudulent marketing practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
327
The slide uses a Q&A transcript format to expose potentially fraudulent sales practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
328
The slide uses highlighted text to emphasize key allegations regarding pressure and compensation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
329
The slide uses a Q&A format to document unethical sales practices, specifically the verbal instruction to expand diagnoses to meet off-label sales goals.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
330
Includes a Q&A transcript excerpt highlighting the 'buddy' system used to submit fake referrals.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
331
The slide uses a Q&A format to highlight discrepancies in prescription volumes across similar-sized territories.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
332
The slide uses a Q&A format to present whistleblower testimony regarding unethical sales practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
333
The slide uses direct quotes to expose potential unethical or illegal marketing practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
334
The slide uses direct quotes from former territory managers to establish the 'unusual' nature of the compensation plan.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
335
The slide uses direct quotes from two different ex-Harmony territory managers to build a case of systemic non-compliance and arbitrary quota setting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
336
The slide uses a Q&A transcript format to highlight the 'weird' nature of the compensation process at Harmony.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
337
The slide uses a Q&A transcript format to highlight alleged unethical practices and lack of transparency in sales compensation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
338
Includes direct Q&A transcript excerpts highlighting the alleged lack of transparency and short-term focus.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
339
The slide uses direct quotes to highlight operational inefficiencies and potential lack of transparency in the patient services process.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
340
The slide uses a Q&A format to highlight the discrepancy between industry standards and Harmony's practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
341
The slide uses highlighted text to emphasize key phrases from expert interviews.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
342
The slide uses a Q&A format to build a case for regulatory or ethical misconduct.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
343
The slide uses a combination of narrative summary and Q&A transcript to build a case of corporate malfeasance.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
344
The slide uses a Q&A format to expose a scheme where management facilitates off-label marketing.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
345
The slide uses a Q&A format to document testimony regarding corporate fraud and off-label promotion.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit